Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
0.1850
-0.0050 (-2.63%)
At close: May 29, 2026, 4:00 PM EDT
0.1875
+0.0025 (1.35%)
After-hours: May 29, 2026, 8:00 PM EDT
Calidi Biotherapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
29
Market Cap
2.85M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 45.00K | -404.00K | -89.98% |
| Dec 31, 2021 | 449.00K | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jaguar Health | 29.57M |
| Ensysce Biosciences | 4.71M |
| Biodexa Pharmaceuticals | 104.90K |
| Azitra | 7.50K |
| Virax Biolabs Group | 2.99K |
CLDI News
- 3 days ago - Calidi announces online abstract acceptances at 2026 ASCO Meeting - TheFly
- 3 days ago - Calidi Biotherapeutics Announces Online Abstract Acceptances at the 2026 ASCO Annual Meeting - GlobeNewsWire
- 7 days ago - Calidi provides required NYSE American disclosure - TheFly
- 7 days ago - Calidi Biotherapeutics Provides Required NYSE American Disclosure - GlobeNewsWire
- 15 days ago - Calidi Biotherapeutics Reports First Quarter 2026 Financial Results and Recent Operational Highlights - GlobeNewsWire
- 16 days ago - Calidi Biotherapeutics Confirms Featured Speaker Presentation Tomorrow at the ASGCT Conference in Boston - GlobeNewsWire
- 4 weeks ago - Calidi Biotherapeutics Announces Strategic Partnership with TransferAI to Drive Efficiencies in the IND Submission Process for CLD-401 Using Agentic AI - GlobeNewsWire
- 5 weeks ago - Calidi presents new data on CLD-401 at AACR - TheFly